Closing the regulatory regress: GMP accreditation in stem cell laboratories.
about
Optimising Translational Research Opportunities: A Systematic Review and Narrative Synthesis of Basic and Clinician Scientists' Perspectives of Factors Which Enable or Hinder Translational ResearchAccelerating Innovation in the Creation of Biovalue: The Cell and Gene Therapy CatapultDoing laboratory ethnography: reflections on method in scientific workplaces.Can harmonized regulation overcome intra-European differences? Insights from a European Phase III stem cell trial.
P2860
Closing the regulatory regress: GMP accreditation in stem cell laboratories.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Closing the regulatory regress: GMP accreditation in stem cell laboratories.
@en
Closing the regulatory regress: GMP accreditation in stem cell laboratories.
@nl
type
label
Closing the regulatory regress: GMP accreditation in stem cell laboratories.
@en
Closing the regulatory regress: GMP accreditation in stem cell laboratories.
@nl
prefLabel
Closing the regulatory regress: GMP accreditation in stem cell laboratories.
@en
Closing the regulatory regress: GMP accreditation in stem cell laboratories.
@nl
P2860
P1476
Closing the regulatory regress: GMP accreditation in stem cell laboratories
@en
P2093
Jamie Lewis
Paul Atkinson
P2860
P304
P356
10.1111/J.1467-9566.2012.01482.X
P577
2012-08-07T00:00:00Z